These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 18386616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U.
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [Abstract] [Full Text] [Related]

  • 7. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Leone G, Barbui T, GIMEMA Chronic Myeloproliferative Neoplasms Working Party.
    Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
    [Abstract] [Full Text] [Related]

  • 8. Polycythemia vera and essential thrombocythemia in young patients.
    Frezzato M, Ruggeri M, Castaman G, Rodeghiero F.
    Haematologica; 1993 Feb; 78(6 Suppl 2):11-7. PubMed ID: 8039752
    [Abstract] [Full Text] [Related]

  • 9. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of specific thrombotic accidents in patients with thrombocytosis.
    Randi ML, Fabris F, Tison T, Barbone E, Rossi C, Girolami A.
    Haematologia (Budap); 1993 Sep; 25(3):149-52. PubMed ID: 8119627
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Vascular complications of essential thrombocythemia].
    Bellucci S.
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [Abstract] [Full Text] [Related]

  • 15. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T, Finazzi G.
    Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F, Colombi M, Calori R, Zilioli VR, Bramanti S, Iurlo A, Zanella A.
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine levels in polycythaemia vera and essential thrombocythaemia.
    Gisslinger H, Rodeghiero F, Ruggeri M, Heis-Vahidi Fard N, Mannhalter C, Papagiannopoulos M, Rintelen C, Lalouschek W, Knöbl P, Lechner K, Pabinger I.
    Br J Haematol; 1999 May; 105(2):551-5. PubMed ID: 10233436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.